Nathan Witmer, PhD

Biography

Mentor: 

Mentor

Ryan L. Boudreau, PhD

Program Start

August 2019

Publications
  • Stein CS, McLendon JM, Witmer NH, and Boudreau RL. Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease. Molecular Therapy - Nucleic Acids, 28: 1-15, 2022. https://doi.org/10.1016/j.omtn.2022.02.007.
  • Stein CS, Jadiya P, Zhang X, McLendon JM, Abouassaly GM, Witmer NH, Anderson EJ, Elrod JW, Boudreau RL.  Mitoregulin: A lncRNA-Encoded Microprotein that Supports Mitochondrial Supercomplexes and Respiratory Efficiency. Cell Reports, 23(13):3710-3720.e8, 2018.  PMCID: PMC6091870
Honors and Awards
  • Predoctoral Fellowship, American Heart Association (23PRE1011277), 2023 - 2024
  • Predoctoral Training Grant in the Pharmacological Sciences (T32 GM067795), 2020 - 2022
  • Molecular Medicine Retreat Poster Presentation Award, Sept 2020
Dissertation Topic

Exploring the Genome: Serendipitous Discoveries in Gene Regulation and Microproteins

Thesis Defense Date

June 30, 2025

Current Position

Postdoctoral Research Fellow

University of Colorado Anschutz Medical Campus

Nathan Witmer PhD
Hometown
Springfield, Missouri
PhD, University of Iowa
Biomedical Science (Molecular Medicine)

BS, University of Iowa
Biochemistry